Weijun Zhao
- Molecular Medicine top 5%
-
- MicroRNA in disease regulation 3
- Modeling and Simulation top 10%
-
- Retinoids in leukemia and cellular processes 3
- Circular RNAs in diseases 3
-
- Cancer Immunotherapy and Biomarkers 3
-
- Immunotherapy and Immune Responses 4
-
- Virus-based gene therapy research 3
-
- Nanoplatforms for cancer theranostics 3
-
- Bioactive Compounds and Antitumor Agents 2
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Weijun Zhao
27 papers receiving 462 citations
Peers
Comparison fields: 5 of 91
- Molecular Medicine 73
- Cancer Research 109
- Modeling and Simulation 18
- Molecular Biology 268
- Oncology 84
Countries citing papers authored by Weijun Zhao
This map shows the geographic impact of Weijun Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijun Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijun Zhao more than expected).
Fields of papers citing papers by Weijun Zhao
This network shows the impact of papers produced by Weijun Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijun Zhao. The network helps show where Weijun Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weijun Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 1 | |
| 7 | 2024 | 6 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 4 | |
| 10 | 2024 | 24 | |
| 11 | 2022 | 9 | |
| 12 | 2022 | 3 | |
| 13 | 2022 | 7 | |
| 14 | 2021 | 10 | |
| 15 | 2020 | 33 | |
| 16 | 2019 | 14 | |
| 17 | 2018 | 22 | |
| 18 | 2006 | 6 | |
| 19 | 2006 | 17 | |
| 20 | 2005 | 32 |
About Weijun Zhao
Weijun Zhao is a scholar working on Toxicology, Cancer Research and Oncology, having authored 32 papers that have together received 469 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), Virus-based gene therapy research (3 papers), MicroRNA in disease regulation (3 papers), Retinoids in leukemia and cellular processes (3 papers), Nanoplatforms for cancer theranostics (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Circular RNAs in diseases (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Molecular Medicine (73 citations), Cancer Research (109 citations) and Modeling and Simulation (18 citations). Weijun Zhao has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Haibo Wang, Zhi‐Dong Lv, Bin Kong, Qian Dong, Funian Li, Xiangping Liu, Yandan Zhang, Chengwei Zhou, Xiaodong Zhao and Rui Yu.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.